Urinary Tract Infection
📧 Sign up to get email alerts when something new happens for Urinary Tract Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-04-07FDA Approved: CEFEPIME HYDROCHLORIDE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application from B. Braun Medical Inc. for Cefepime hydrochloride and dextrose, adding this formulation under th…
-
FDA approval · 2026-04-07FDA Approved: NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) — Original Application (Creekwood Pharmaceuticals LLC)
The FDA approved Creekwood Pharmaceuticals LLC's generic nitrofurantoin monohydrate/macrocrystals through an original ANDA.
-
EMA approval · 2026-03-23EMA Authorised: Vaborem (meropenem trihydrate;vaborbactam) — Menarini International Operations Luxembourg S.A.
The European Medicines Agency authorised Vaborem, a meropenem trihydrate and vaborbactam combination, for use in several infections. It cove…
-
EMA approval · 2026-02-23EMA Authorised: Emblaveo (avibactam;aztreonam) — Pfizer Europe MA EEIG
The EMA authorised Emblaveo (avibactam/aztreonam) for treating certain Gram-negative bacterial infections, including urinary tract infection…
-
EMA approval · 2025-11-14EMA Authorised: Zavicefta (avibactam sodium;ceftazidime pentahydrate) — Pfizer Ireland Pharmaceuticals Unlimited Company
The EMA authorised Zavicefta (avibactam sodium and ceftazidime pentahydrate) for treatment of pneumonia, soft tissue infections, urinary tra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-07-02FDA Approved: NITROFURANTOIN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original ANDA for nitrofurantoin, a generic antibiotic. The approval covers its use for urinary tract i…
-
FDA approval · 2025-06-03FDA Approved: FOSFOMYCIN TROMETHAMINE — Original Application (Precision Dose, Inc.)
The FDA approved an original application for fosfomycin tromethamine by Precision Dose, Inc., marking the availability of this generic antib…
-
FDA approval · 2025-03-21FDA Approved: NITROFURANTOIN MACROCRYSTALS — Supplemental Application (Lifestar Pharma LLC)
FDA approved a supplemental application for nitrofurantoin macrocrystals from Lifestar Pharma LLC, indicating an approved change to this pro…
-
FDA approval · 2025-03-21FDA Approved: NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) — Supplemental Application (NorthStar RxLLC)
The FDA approved a supplemental application for nitrofurantoin monohydrate/macrocrystals from NorthStar RxLLC, finalizing approval of a gene…
-
FDA approval · 2025-03-10FDA Approved: METHENAMINE HIPPURATE — Original Application (Zydus Lifesciences Limited)
FDA approved an original ANDA for methenamine hippurate from Zydus Lifesciences Limited, establishing this drug as a generic option for urin…
-
FDA approval · 2025-02-21FDA Approved: SULFAMETHOXAZOLE AND TRIMETHOPRIM — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application from Prasco Laboratories for sulfamethoxazole and trimethoprim, granting approval of a generic p…
-
FDA approval · 2025-02-18FDA Approved: NITROFURANTOIN MACROCRYSTALS — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Nitrofurantoin Macrocrystals.
-
FDA approval · 2025-01-14FDA Approved: NITROFURANTOIN — Original Application (Somerset Therapeutics, LLC)
FDA approved an original application for nitrofurantoin from Somerset Therapeutics, LLC. The product is intended for treatment of urinary tr…
-
FDA approval · 2024-10-28FDA Approved: NITROFURANTOIN — Original Application (Biocon Pharma Inc)
The FDA approved Biocon Pharma Inc's original ANDA for nitrofurantoin, a generic antibiotic used to treat urinary tract infections.
-
FDA approval · 2024-10-02FDA Approved: NITROFURANTOIN (MACROCRYSTALS) — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for nitrofurantoin macrocrystals (nitrofurantoin) from Aurobindo Pharma Limited, representing a supp…
-
FDA approval · 2024-06-24FDA Approved: SULFAMETHOXAZOLE AND TRIMETHOPRIM — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for sulfamethoxazole and trimethoprim by Prasco Laboratories. This action confirms the approval of t…
-
FDA approval · 2024-06-20FDA Approved: NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved Jubilant Cadista Pharmaceuticals' supplemental application for nitrofurantoin monohydrate/macrocrystals, a generic nitrofuranto…
-
FDA approval · 2024-05-01FDA Approved: PIPERACILLIN AND TAZOBACTAM — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for Civica, Inc. for Piperacillin and Tazobactam (piperacillin/tazobactam).
-
FDA approval · 2024-04-25FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (NorthStar Rx LLC)
FDA approved a Supplemental Application for Amoxicillin and clavulanate potassium by NorthStar Rx LLC, indicating a modification to an exist…
-
FDA approval · 2024-04-24FDA Approved: PIVYA — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves PIVYA (pivmecillinam) from Alembic Pharmaceuticals Inc. under an original NDA for urinary tract infections.
-
FDA approval · 2024-04-24FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2024-04-12FDA Approved: NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
The FDA approved Jubilant Cadista Pharmaceuticals' supplemental application for nitrofurantoin (monohydrate/macrocrystals).
-
EMA approval · 2024-03-22EMA Authorised: Exblifep (cefepime dihydrochloride monohydrate;Enmetazobactam) — Advanz Pharma Limited
Exblifep has been authorised for multiple infections including urinary tract infections, pyelonephritis, healthcare-associated pneumonia, an…
-
FDA approval · 2023-12-11FDA Approved: NITROFURANTOIN (MACROCRYSTALS) — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for nitrofurantoin (Macrocrystals) from Aurobindo Pharma Limited.
-
FDA approval · 2023-12-11FDA Approved: NITROFURANTOIN (MACROCRYSTALS) — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for nitrofurantoin macrocrystals from Aurobindo Pharma Limited.